Clinical Trials in Arizona

Showing 2901-2920 of 16,770 trials

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

NCT06071845

This clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoing endoscopy. Non-endoscopic swallowable encapsulate sponge cell collection devices combined with markers for BE/esophageal adenocarcinoma (EAC) detection are a guideline-endorsed alternative to endoscopy for BE screening. The Oncoguard registered trademark Esophagus test (OGE) test uses esophageal cytology specimens collected with a minimally invasive, non-endoscopic, encapsulated sponge sampling device to identify BE/EAC biomarkers that indicate whether a patient should undergo diagnostic endoscopy. The OGE test is a simple and cost effective screening method that may lower barriers to widespread adoption of BE screening in at risk patients, resulting in increased and earlier detection of BE/EAC.

Barrett EsophagusBarretts Esophagus With DysplasiaBarrett's Esophagus Without Dysplasia+1 more

Mayo Clinic400 participantsStarted Oct 2023

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Chicago, Illinois, United States +2 more locations

COMPLETEDPhase 435 miles

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

NCT05217927

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.

Migraine

Pfizer1,415 participantsStarted Mar 2022

Tempe, Arizona, United States • Colton, California, United States • Los Angeles, California, United States +104 more locations

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Find Trials by Condition in Arizona

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

BHV-7000 Open-Label Extension Bipolar Mania Study

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV